Clinical Trials in Philadelphia

Showing 12341-12360 of 20,904 trials

Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

NCT00006400

The purpose of this study is to determine if hydroxyurea therapy is effective in the prevention of chronic end organ damage in pediatric patients with sickle cell anemia.

Hematologic DiseasesAnemia, Sickle Cell

National Heart, Lung, and Blood Institute (NHLBI)193 participantsStarted Aug 2000

Birmingham, Alabama, United States • Washington D.C., District of Columbia, United States • Washington D.C., District of Columbia, United States +11 more locations

COMPLETEDPhase 2< 1 mile

Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving

NCT01151813

This is a Phase II within-subjects double-blind placebo-controlled human laboratory study. The purpose of the study is to determine the efficacy of varenicline (Chantix) for reducing cue-induced cocaine and alcohol craving.

Alcohol DependenceCocaine Dependence

University of Pennsylvania15 participantsStarted Jul 2010

Philadelphia, Pennsylvania, United States

Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving

Find Trials by Condition in Philadelphia

Pyloric Sphincter Pressure and Geometry Assessment Using EndoFlip

Electrogastrogram (EGG) Reproducibility Study: EEG Readings in Normal Subjects and Dyspeptic Patients

Non-invasive Measurement of Cerebral Dynamic Autoregulation

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

A Safety Study of NNZ-2566 in Pediatric Rett Syndrome

Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease

Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

OIT and Xolair® (Omalizumab) in Cow's Milk Allergy

Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma

TMT Fusion Plate vs. Two Crossed Screws

Nasal High Flow Therapy 30 Day Readmission Study

Clinical and Device Functional Assessment of Real World ICD Patients

A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis